-
·
AML Biomarkers
Join AML expert Dr. Stephen Strickland to learn how biomarker testing can unlock treatment options for NPM1, IDH, KMT2A, and RUNX1 mutations.
-
·
Filipe’s Stage 4 Lung Cancer with EGFR exon 19 Deletion Story
Filipe P., Non-Small Cell Lung Cancer with EGFR Exon 19 Deletion, Stage 4 (Metastatic) Symptom: Headache Treatments: Surgery (to remove brain metastasis), cryoablation (to remove kidney metastasis), targeted therapy, SBRT, bispecific antibody
-
·
Samantha’s Stage 4 HER2 Non-Small Cell Lung Cancer Story
Samantha M., Non-Small Cell Lung Cancer, HER2+, Stage 4 (Metastatic) Symptoms: Persistent cough, chest pressure, fatigue, weight loss Treatments: Chemotherapy, immunotherapy
